By Randy Ellis
NORMAN − A Johnson & Johnson subsidiary received a stern warning from the U.S. Food and Drug Administration in 2004 for using promotional materials that contained "false or misleading claims" about the effectiveness and abuse potential of its Duragesic opioid patch.
That FDA warning to Janssen Pharmaceuticals Inc., was among many documents entered into evidence Thursday during the third day of a trial in Cleveland County District Court.
Oklahoma Attorney General Mike Hunter has accused Johnson & Johnson and its subsidiaries of creating an opioid epidemic by oversupplying the state with the painkillers and making misleading marketing claims about their effectiveness and addictive risks.
Hunter wants Judge Thad Balkman to declare Johnson & Johnson's actions to be a public nuisance and order the company to pay billions of dollars to abate the problem.
Two other groups of opioid manufacturers, one headed by Purdue Pharma and the other by Teva Pharmaceuticals USA Inc., have previously agreed to settle the state's cases against them.
Read more on NewsOK.com